from FOX News https://ift.tt/3g3lhFV
FDA greenlights targeted therapy for lung cancer mutation
The Food and Drug Administration has approved the first drug for a specific mutation causing lung cancer in adult patients who have undergone at least one systemic treatment, such as chemotherapy.
from FOX News https://ift.tt/3g3lhFV
from FOX News https://ift.tt/3g3lhFV
Related Posts:
Omicron: Pfizer says COVID pill appears effective against variant- Deadline time for HealthCare.gov coverage that starts Jan. 1
- WHO director warns omicron spreading at rate 'not seen with any previous' variant
- FDA faces legal challenge over COVID-19 approval data, report says
- Omicron variant: Pfizer vaccine protects 70% against hospitalization, study finds
0 comments:
Post a Comment